Business Description
Paxman AB
ISIN : SE0009806284
Total Employee Number:
102Compare
Compare
Traded in other countries / regions
PAX.SwedenB0F.GermanyPXMBF.USA IPO Date
2017-06-12Description
Paxman AB is a Sweden-based company engaged in the development of the PAXMAN Scalp Cooling System, which has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The portfolio includes both the Paxman and Digni Capsystems with several installations in hospitals, clinics, and treatment centres world-wide.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 23.17 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.16 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 10.95 | |||||
Beneish M-Score | -2.04 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.4 | |||||
3-Year EBITDA Growth Rate | 14.5 | |||||
3-Year EPS without NRI Growth Rate | -10.1 | |||||
3-Year FCF Growth Rate | 26.5 | |||||
3-Year Book Growth Rate | 42.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 30.09 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 31.57 | |||||
9-Day RSI | 33.65 | |||||
14-Day RSI | 35.59 | |||||
3-1 Month Momentum % | 1.85 | |||||
6-1 Month Momentum % | -3.7 | |||||
12-1 Month Momentum % | -39.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.54 | |||||
Quick Ratio | 3.8 | |||||
Cash Ratio | 2.13 | |||||
Days Inventory | 105.81 | |||||
Days Sales Outstanding | 67.7 | |||||
Days Payable | 71.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7 | |||||
Shareholder Yield % | 0.2 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 66.65 | |||||
Operating Margin % | -0.39 | |||||
Net Margin % | -3.2 | |||||
EBITDA Margin % | 8.66 | |||||
FCF Margin % | -6.9 | |||||
OCF Margin % | -0.67 | |||||
ROE % | -2.76 | |||||
ROA % | -2.37 | |||||
ROIC % | -0.44 | |||||
3-Year ROIIC % | 2.48 | |||||
ROC (Joel Greenblatt) % | -1.37 | |||||
ROCE % | -0.33 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 25.35 | |||||
PS Ratio | 3.15 | |||||
PB Ratio | 2.62 | |||||
Price-to-Tangible-Book | 4.93 | |||||
EV-to-EBIT | -737.34 | |||||
EV-to-EBITDA | 33.46 | |||||
EV-to-Revenue | 2.9 | |||||
EV-to-Forward-Revenue | 1.91 | |||||
EV-to-FCF | -42.56 | |||||
Price-to-GF-Value | 0.73 | |||||
Price-to-Projected-FCF | 4.08 | |||||
| Price-to-Net-Current-Asset-Value | 6.73 | |||||
| Price-to-Net-Cash | 27.15 | |||||
Earnings Yield (Greenblatt) % | -0.13 | |||||
FCF Yield % | -2.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Paxman AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 335.773 | ||
| EPS (TTM) (kr) | -0.48 | ||
| Beta | 0.4404 | ||
| 3-Year Sharpe Ratio | 0.54 | ||
| 3-Year Sortino Ratio | 0.91 | ||
| Volatility % | 34.88 | ||
| 14-Day RSI | 35.59 | ||
| 14-Day ATR (kr) | 1.861382 | ||
| 20-Day SMA (kr) | 47.91 | ||
| 12-1 Month Momentum % | -39.63 | ||
| 52-Week Range (kr) | 41 - 83.6 | ||
| Shares Outstanding (Mil) | 23.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Paxman AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Paxman AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-20 | In 114 days | ||
| Second quarter earnings results for 2026 | 2026-08-21 | In 23 days | ||
| General meeting for 2025 | 2026-05-22 10:00 | 50.00 (-0.60%) | ||
| First quarter earnings results for 2026 | 2026-05-21 | 49.95 (-0.10%) | ||
| Annual report for 2025 | 2026-04-24 | 48.00 (-1.84%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-27 | 50.20 (+0.80%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 64.60 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-20 | 74.40 (-4.12%) | ||
| General meeting for 2024 | 2025-05-16 10:00 | 75.80 (-2.32%) | ||
| First quarter earnings results for 2025 | 2025-05-16 | 75.80 (-2.32%) |
Show
Entries
Paxman AB Frequently Asked Questions
What is Paxman AB(OSTO:PAX)'s stock price today?
The current price of OSTO:PAX is kr46.15. The 52 week high of OSTO:PAX is kr83.60 and 52 week low is kr41.00.
When is next earnings date of Paxman AB(OSTO:PAX)?
The next earnings date of Paxman AB(OSTO:PAX) is 2026-08-21.
Does Paxman AB(OSTO:PAX) pay dividends? If so, how much?
Paxman AB(OSTO:PAX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Paxman AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers